Skip to main content

North Clybourn office has been closed. Our new office is located at: 2338 N Clark Street.

Home » What’s New » Embracing New Hope in Macular Degeneration Treatment

Embracing New Hope in Macular Degeneration Treatment

senior woman at an eye exam

At Eye Mechanix in La Grange, a patient named Sarah had been managing her macular degeneration with traditional treatments for years. Despite her efforts, she noticed her vision was gradually declining, making daily activities increasingly challenging.

Determined to find a better solution, Sarah scheduled a consultation with our specialists to explore the latest advancements in macular degeneration treatments. This decision opened new avenues for managing her condition and preserving her vision.

Understanding Macular Degeneration

Macular degeneration is a progressive eye condition affecting the macula, the central part of the retina responsible for sharp, detailed vision. It is a leading cause of vision loss, particularly in individuals over 50. The disease manifests in two primary forms:

  • Dry Macular Degeneration: Characterized by the thinning of the macula, leading to gradual vision loss.
  • Wet Macular Degeneration: Involves abnormal blood vessel growth under the retina, causing rapid and severe vision impairment.

Innovative Treatments for Macular Degeneration

Recent advancements have led to promising treatments aimed at slowing disease progression and preserving vision:

  1. Anti-VEGF Injections: These medications inhibit the growth of abnormal blood vessels in the eye, effectively managing wet macular degeneration. Newer drugs target multiple pathways involved in disease progression, potentially reducing the frequency of injections.
  2. Gene Therapy: Emerging gene therapies aim to provide long-term treatment by enabling the eye to produce its own protective proteins, potentially reducing or eliminating the need for regular injections. While still under investigation, these therapies offer hope for more sustainable disease management.
  3. Complement Inhibitors: For advanced dry macular degeneration, treatments like Pegcetacoplan (Syfovre) have been approved to slow disease progression by inhibiting specific components of the immune system that contribute to retinal damage.

Personalized Care at Eye Mechanix

At Eye Mechanix, serving patients in Lincoln Park and La Grange, we are committed to providing personalized care tailored to each patient's unique needs. Our experienced team stays abreast of the latest developments in macular degeneration treatments to offer the most effective options available.

During your consultation, we will conduct a comprehensive eye exam and discuss the most suitable treatment strategies, considering factors such as disease stage, lifestyle, and overall health. Our goal is to empower you with the knowledge and resources necessary to manage your condition effectively and maintain your quality of life.

Book Your Eye Exam in Lincoln Park and La Grange, IL

Discover the latest treatment options with our eye doctors. Schedule a consultation at Eye Mechanix in Lincoln Park or La Grange to learn how we can help you manage macular degeneration and preserve your vision.